Aclaris Therapeutics
ACRS
ACRS
133 hedge funds and large institutions have $815M invested in Aclaris Therapeutics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
1.22% less ownership
Funds ownership: 92.76% → 91.53% (-1.2%)
20% less capital invested
Capital invested by funds: $1.02B → $815M (-$208M)
Holders
133
Holding in Top 10
8
Calls
$2.15M
Puts
$31K
Top Buyers
| 1 | +$9.05M | |
| 2 | +$7.01M | |
| 3 | +$4.86M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$4.69M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.43M |
Top Sellers
| 1 | -$35.2M | |
| 2 | -$10.7M | |
| 3 | -$8.72M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$8.52M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$6.03M |